Fidelity Investments
DMRA

Fidelity Investments’s Damora Therapeutics DMRA Stock Holding History

Fidelity Investments’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$240M Buy
9,232,979
+187,498
+2% +$4.54M 0.01% 854
2026
Q1 		$234M Buy
9,045,481
+8,806,603
+3,687% +$226M 0.01% 790
2025
Q4 		$5.5M Buy
+238,878
New +$4.15M ﹤0.01% 2255
2021
Q2 		– Sell
-5,333
Closed -$810K – 4492
2021
Q1 		$810K Hold
5,333
– – ﹤0.01% 2616
2020
Q4 		$1.67M Buy
+5,333
New +$1.98M ﹤0.01% 2438

Other funds holding DMRA

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RCP
Remedium Capital Partners Fort Lauderdale, Florida $452M AUM
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Fidelity Investments's DMRA Position: Q2 2026 in Review

Fidelity Investments increased its Damora Therapeutics (DMRA) stake by 2.1% in Q2 2026, buying an estimated $4.54M and bringing the position to 9,232,979 shares worth $240M. The position accounts for 0.01% of the portfolio, ranked #854.

Fidelity Investments first reported a position in DMRA in Q4 2020 and has held it in 5 quarters since. 104 funds tracked by Wall St. Rank hold DMRA as of Q2 2026.

  • Fidelity Investments held 9,232,979 shares of Damora Therapeutics worth $240M as of Q2 2026.
  • Fidelity Investments bought 187,498 Damora Therapeutics shares in Q2 2026, an estimated $4.54M.
  • Damora Therapeutics made up 0.01% of Fidelity Investments's portfolio in Q2 2026, its #854 holding.
  • Fidelity Investments first reported a position in Damora Therapeutics in Q4 2020 and has held it in 5 quarters since.
  • 104 funds tracked by Wall St. Rank held Damora Therapeutics as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.